MRI-Based Diagnostic Model for Alzheimer's Disease Using 3D-ResNet.
Authors
Affiliations (4)
Affiliations (4)
- College of science, Northeast Forestry University, Northeast Forestry University, Harbin, 150040, CHINA.
- Research Institute of Intelligent Control and Systems Harbin Institute of Technology, Research Institute of Intelligent Control and Systems Harbin Institute of Technology, Harbin, 150040, CHINA.
- Northeast Forestry University, Northeast Forestry University, Harbin, Heilongjiang, 150040, CHINA.
- Northeast Forestry University, Northeast Forestry University, Harbin, 150040, CHINA.
Abstract
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the leading cause of dementia worldwide and remains incurable once it begins. Therefore, early and accurate diagnosis is essential for effective intervention. Leveraging recent advances in deep learning, this study proposes a novel diagnostic model based on the 3D-ResNet architecture to classify three cognitive states: AD, mild cognitive impairment (MCI), and cognitively normal (CN) individuals, using MRI data. The model integrates the strengths of ResNet and 3D convolutional neural networks (3D-CNN), and incorporates a special attention mechanism(SAM) within the residual structure to enhance feature representation. The study utilized the ADNI dataset, comprising 800 brain MRI scans. The dataset was split in a 7:3 ratio for training and testing, and the network was trained using data augmentation and cross-validation strategies. The proposed model achieved 92.33% accuracy in the three-class classification task, and 97.61%, 95.83%, and 93.42% accuracy in binary classifications of AD vs. CN, AD vs. MCI, and CN vs. MCI, respectively, outperforming existing state-of-the-art methods. Furthermore, Grad-CAM heatmaps and 3D MRI reconstructions revealed that the cerebral cortex and hippocampus are critical regions for AD classification. These findings demonstrate a robust and interpretable AI-based diagnostic framework for AD, providing valuable technical support for its timely detection and clinical intervention.